<DOC>
	<DOCNO>NCT00450762</DOCNO>
	<brief_summary>The rational trial give knowledge gemcitabine act potent inhibitor DNA repair therefore may prevent adequate repair platin-induced DNA damage . Gemcitabine excellent choice combination therapy unique mechanism action favourable toxicity profile . The combination gemcitabine cisplatin show effective several trial , produce response rate 30-52 % patient pretreated metastatic breast cancer . To improve tolerability handle regime carboplatin may appropriate choice treatment . The mechanism action carboplatin similar cisplatin . The rational combining gemcitabine carboplatin base single-agent activity metastatic breast cancer , activity combination malignancy fact carboplatin demonstrate efficacy comparable cisplatin several tumor type .</brief_summary>
	<brief_title>Gemcitabine + Carboplatin Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically confirm metastatic breast cancer All patient require give write informed consent . Prior treatment chemotherapy , hormonal therapy , immunotherapy local radiotherapy allow ( except gemcitabine platinum agent ) . Patients require least one bidimensionally measurable lesion outside previous radiation port . Age ≥ 18 year Karnofsky Performance status ≥ 70 % Minimal life expectancy 12 week Adequate haematological , renal , cardiac hepatic function : 1 . Leukocyte count ≥ 3.0 x 109/l 2 . Absolute neutrophil count ≥ 2.0 x 109/l 3 . Platelet count ≥ 100 x 109/l 4 . Haemoglobin ≥ 8 g/dl 5 . Total serum bilirubin ≤ 1.25 x upper limit normal ( ULN ) In presence liver metastasis ≤ 3 x ULN 6 . Transaminase ( ALT , AST ) level ≤ 3 x ULN In presence liver metastasis ≤ 5 x ULN 7 . Alkaline phosphatase level ≤ 2.5 x ULN 8 . Creatinine clearance require exceed 60 ml/min . Prior treatment gemcitabine platinum agent Inadequate creatinine clearance ( &lt; 60 ml/min ) Only bone metastasis Symptomatic brain metastasis Women pregnant , lactate refuse effective contraception Secondary malignancy History another primary malignant disease situ carcinoma uterine cervix adequately treat basal cell skin cancer Active infection Any concomitant severe clinical condition make implementation protocol include prehydration difficult .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>pretreated</keyword>
	<keyword>metastatic</keyword>
</DOC>